Retractable Technologies RVP
NYSE RVP
$0.71 -0.01 (-0.78%)
As of: Sep 10, 2026 · 12:06 PM EDT

Retractable Technologies (RVP) Research & Development (2010 - 2026)

Retractable Technologies' (RVP) quarterly Research & Development came in at $1.5 million in Q2 2026, down 7.64% on a YoY basis from $1.7 million in Q2 2025, and down 11.49% quarter-over-quarter from $1.7 million in Q1 2026.

Analysis

Retractable Technologies (RVP) Research & Development (2010 - 2026) Analysis & Trends

Retractable Technologies (RVP) has reported Research & Development for 17 consecutive years, with $1.5 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Research & Development fell 7.64% year-over-year to $1.5 million; the trailing twelve-month figure through Jun 2026 stood at $6.8 million (up 10.04% YoY), and the FY2025 full-year result was $6.8 million, up 16.61% from the prior year.
  • Research & Development declined to $1.5 million in Q2 2026 per RVP's latest filing, from $1.7 million in the prior quarter.
  • Across five years, Research & Development topped out at $2.0 million in Q4 2025 and bottomed at $1.0 million in Q1 2022.
  • Historically, Research & Development has averaged $1.5 million across 5 years, with a median of $1.5 million in 2023.
  • The sharpest annual moves came in 2022 and 2025: Research & Development fell 26.36% in 2022, then jumped 65.8% in 2025.
  • Over 5 years, Research & Development stood at $1.3 million in 2022, then increased by 12.22% to $1.4 million in 2023, then fell by 17.54% to $1.2 million in 2024, then surged by 65.8% to $2.0 million in 2025, then dropped by 22.19% to $1.5 million in 2026.
  • According to Business Quant data, Research & Development over the past three periods registered $1.5 million, $1.7 million, and $2.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Becton Dickinson 48.41 Bn 47.55 Bn 2.32 Bn 258.00 Mn
2 Medline 27.78 Bn 25.10 Bn 2.22 Bn -
3 West Pharmaceutical Services 24.42 Bn 23.98 Bn 329.20 Mn 19.70 Mn
4 Baxter International 12.49 Bn 10.34 Bn 1.03 Bn 129.00 Mn
5 Stevanato Group S.p.A 5.70 Bn 5.59 Bn 100.91 Mn 7.22 Mn
6 Acme United 235.29 Mn 230.25 Mn 26.69 Mn -
7 Rockwell Medical 31.39 Mn 6.60 Mn 3.24 Mn 577,000.00
8 Retractable Technologies 21.15 Mn -18.72 Mn 190,852.00 1.53 Mn
9 United Health Products 8.85 Mn 8.82 Mn - 3,852.00
10 Cuprina Holdings (Cayman) 7.88 Mn 4.76 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.53 Mn
Mar 31, 2026 1.73 Mn
Dec 31, 2025 1.97 Mn
Sep 30, 2025 1.58 Mn
Jun 30, 2025 1.66 Mn
Mar 31, 2025 1.60 Mn
Dec 31, 2024 1.19 Mn
Sep 30, 2024 1.75 Mn
Jun 30, 2024 1.47 Mn
Mar 31, 2024 1.43 Mn
Dec 31, 2023 1.44 Mn
Sep 30, 2023 1.37 Mn
Jun 30, 2023 1.55 Mn
Mar 31, 2023 1.35 Mn
Dec 31, 2022 1.29 Mn
Sep 30, 2022 1.17 Mn
Jun 30, 2022 1.07 Mn
Mar 31, 2022 1.02 Mn
Dec 31, 2021 1.08 Mn
Sep 30, 2021 1.02 Mn